SCHEMBL772162

SCHEMBL772162

CC(NC(=O)CCCC(=O)N1CCCC2CCCCC21)C(O)c1ccc(O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 2/20 0.44
ALDH1A1 P00352 1/20 0.42
ASAH1 Q13510 1/20 0.42
ACER2 Q5QJU3 1/20 0.42
DPP4 P27487 1/20 0.38
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACE P12821 5/20 0.35
ACE2 Q9BYF1 3/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
HSD11B1 P28845 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GMNN O75496 1/20 0.34
PMP22 Q01453 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10138695 0.91 ALDH1A1 (0.53) UGCGALDH1A1ASAH1ACER2DPP4
SCHEMBL771811 0.91 ALDH1A1 (0.53) UGCGALDH1A1ASAH1ACER2DPP4
SCHEMBL770561 0.89 ALDH1A1 (0.41) UGCGALDH1A1ASAH1ACER2DPP4
SCHEMBL771118 0.79 PRCP (0.50) ALDH1A1DPP4DRD2NPC1RAB9A
SCHEMBL772523 0.79 PRCP (0.50) ALDH1A1DPP4DRD2NPC1RAB9A
SCHEMBL10138281 0.78 HDAC1 (0.46) ALDH1A1ACEACE2NPSR1
SCHEMBL17690709 0.77 TRPV1 (0.46) DPP4DRD2DRD4NPC1RAB9A
SCHEMBL802601 0.77 ALDH1A1 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2ACE
SCHEMBL770465 0.75 DPP4 (0.45) DPP4DRD2DRD4NPC1RAB9A
SCHEMBL772163 0.74 DPP4 (0.42) DPP4DRD2DRD4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 UGCG 1010/4885ALDH1A1 144/4885ASAH1 143/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 UGCG 1019/4885ALDH1A1 142/4885ASAH1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.